Nasdaq

Modeling Data Showed Cologuard® Was Superior to Fecal Immunochemical Test (FIT) on Cost Effectiveness and Colorectal Cancer Incidence and Mortality

MADISON, Wis., May 21, 2021 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today highlights data from one oral and one poster presentation being featured at the 2021 Digestive Disease Week® (DDW® ...
Nasdaq

Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening

Note: specificity including non-advanced findings includes colonoscopy results that were negative for cancer or advanced precancer upon histopathological review; specificity including no findings ...
Hosted on MSN

Cologuard Plus: An improved at-home colon cancer test

Cologuard Plus, a new version of the Cologuard colorectal screening test, became available in 2025. The manufacturer says the upgraded test may be 30% more accurate than the original Cologuard. If you ...
Healio

FDA approves Cologuard Plus, Exact Sciences’ next generation stool test for CRC screening

Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...
Seeking Alpha

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922874822/en/ Horror icon Matthew Lillard is teaming ...
Business Wire

Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded partnership with Humana Inc. to enhance ...
Becker's ASC

4 gastroenterologists share their thoughts on Exact Sciences’ Cologuard

Exact Sciences completed 1.69 million Cologuard tests in 2019, and while the test was found to have 92 percent sensitivity and 87 percent specificity rates for detecting colorectal cancer, it remains ...
AOL

He got an at-home colon cancer test in the mail. The problem? He doesn't have a colon.

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...
USA Today

Stool tests like Cologuard are gaining popularity over colonoscopy. Which should you get?

A colonoscopy is recommended every decade for people over 45. The screening is used to detect colon cancer. But roughly 40% of eligible Americans don't get a colonoscopy, often because they don't want ...
Oklahoma's News

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard Test

MADISON, Wis., Dec. 20, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, supports recent policy changes that help increase access ...
Morningstar

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Potentially awkward conversations and 90s nostalgia combine to drive accessible screening for adults 45+ Learn more at Cologuard.com/TheTalk "The (Second) Talk ...
Business Insider

Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for ...

American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study results versus FIT at ACG High specificity for ...